From: Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?
Study
Histology
SCC (%)
Treatment
n
MS (months)
5-year OS (%)
P value
Pouliquen and colleagues [46]
SCC
100
CF
52
13
NS
Surgery
68
14
Ando and colleagues [47]
CV
45
105
48
Ando and colleagues [25]
120
61
122